Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Feyer

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 5, 2013
DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancerF Sedlmayer, M-L Sautter-Bihl, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 30, 2012
When are breast cancer patients old enough for the quitclaim of local control?M L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 24, 2012
One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgeryM L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2014
How nescience may obscure evidenceM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2016
DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrencesWolfgang Harms, W Budach, J Dunst, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathwaysM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 2020
DEGRO practical guideline for partial-breast irradiationV Strnad, D Krug, F Sedlmayer, et al.
Journal of the Royal Society, Interface|April 4, 2019
Fly with the flock: immersive solutions for animal movement visualization and analyticsKarsten Klein, Björn Sommer, Hieu T Nim, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy TreatmentJ P LeBourgeois, C J McKenna, B Coster, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 20, 2015
Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastasesWilfried Budach, C Matuschek, E Bölke, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 5, 2013
DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancerF Sedlmayer, M-L Sautter-Bihl, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 30, 2012
When are breast cancer patients old enough for the quitclaim of local control?M L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 24, 2012
One life saved by four prevented recurrences? Update of the Early Breast Cancer Trialists confirms: postoperative radiotherapy improves survival after breast conserving surgeryM L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2014
How nescience may obscure evidenceM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2016
DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrencesWolfgang Harms, W Budach, J Dunst, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
DEGRO practical guidelines: radiotherapy of breast cancer III--radiotherapy of the lymphatic pathwaysM-L Sautter-Bihl, F Sedlmayer, W Budach, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 2020
DEGRO practical guideline for partial-breast irradiationV Strnad, D Krug, F Sedlmayer, et al.
Journal of the Royal Society, Interface|April 4, 2019
Fly with the flock: immersive solutions for animal movement visualization and analyticsKarsten Klein, Björn Sommer, Hieu T Nim, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy TreatmentJ P LeBourgeois, C J McKenna, B Coster, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 20, 2015
Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastasesWilfried Budach, C Matuschek, E Bölke, et al.
Pageof 4